Status:
UNKNOWN
The Surveillance Clinical Study of Rickettsiosis
Lead Sponsor:
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Conditions:
Rickettsiosis
Eligibility:
All Genders
Brief Summary
The purpose of this surveillance (non-interventional) clinical study is to genotype the causative agents of rickettsiosis in biological samples of patients from the Altai Republic, Russian Federation....
Eligibility Criteria
Inclusion
- Written patient's informed concent for study participation;
- Male and female patients of any age with diagnosed or suspected tick-born rickettsioses.
Exclusion
- \- Unwillingness to participate in the study by any reason.
Key Trial Info
Start Date :
April 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06162975
Start Date
April 1 2023
End Date
November 30 2023
Last Update
December 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Altai Republic Center for HIV prophylaxis and treatment
Gorno-Altaysk, Altai Republic, Russia, 649002